Skip to main content
BSF ENTERPRISE PLC logo

BSF ENTERPRISE PLC — Investor Relations & Filings

Ticker · BSFA ISIN · GB00BHNBDQ51 LEI · 2138007PJT69H8FYLC06 IL Professional, scientific and technical activities
Filings indexed 177 across all filing types
Latest filing 2026-06-11 Capital/Financing Update
Country GB United Kingdom
Listing IL BSFA

About BSF ENTERPRISE PLC

https://bsfenterprise.com/

BSF Enterprise PLC is a biotechnology company that develops and commercializes cell-based, tissue-engineered solutions. The company focuses on creating innovative materials and products for various applications, including cultivated meat, lab-grown leather, and technologies for corneal repair. The core business model involves acquiring and advancing proprietary technologies in cellular agriculture and regenerative medicine with the objective of licensing its intellectual property.

Recent filings

Filing Released Lang Actions
£1 Million Convertible Loan Note
Capital/Financing Update Classification · 95% confidence The document is an RNS announcement by BSF Enterprise PLC detailing the terms and funding committed under a £1 million interest-free Convertible Loan Note, including conversion and warrant terms. This is a financing update on the company’s capital structure rather than an earnings release, share issue notice, or regulatory procedural filing. Therefore it fits the Capital/Financing Update category.
2026-06-11 English
Shareholder meeting results
Declaration of Voting Results & Voting Rights Announcements Classification · 15% confidence The document is an RNS announcement detailing the poll results of all resolutions at a company’s General Meeting, including voting percentages, total voting rights and share admission. This falls squarely under “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-06-08 English
Conditional Further Investment
Capital/Financing Update Classification · 92% confidence The document is an RNS announcement by BSF Enterprise PLC regarding a conditional placing of 25 million new ordinary shares to raise £500,000, the issue of broker warrants, admission details, and the total voting rights post-placement. This is a capital raising/financing update rather than an actual financial report, dividend, or regulatory filing of a different nature. It fits the definition of a Capital/Financing Update.
2026-06-03 English
Technical White Paper on T-Rex Leather™
Regulatory Filings Classification · 87% confidence The document is an RNS announcement from BSF Enterprise PLC stating that its subsidiary has published a technical white paper on T-Rex Leather™. It contains no financial statements or regulatory certifications; it’s simply a news release linking to an external research paper. This falls into the general “Regulatory Filings” (RNS) category as a miscellaneous corporate announcement rather than a formal financial report or specific filing type.
2026-06-02 English
Auction Update - May 2026
Regulatory Filings Classification · 80% confidence The document is an RNS press release via the London Stock Exchange’s National Storage Mechanism announcing an auction update for a subsidiary’s unique asset. It contains no financial statements, no voting results, no M&A activity, no director changes, and no regulatory certification—just a corporate news announcement. It falls under the generic Regulatory Filings category (RNS).
2026-05-28 English
Strategic Update May 2026
Regulatory Filings Classification · 88% confidence The document is an RNS announcement titled “Strategic Update May 2026” with no financial statements, no earnings data, and no formal fundraising or capital structure change. It provides a high-level operational and commercial update rather than the actual report or presentation. This falls under the general regulatory announcement fallback category.
2026-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.